Multiple indirect cellular targets via secreted trophic factors and cytokines

Multiple indirect cellular targets via secreted trophic factors and cytokines refers to a therapeutic paradigm, primarily associated with cell-based therapies like mesenchymal stem cells (MSCs), where the primary mode of action is the paracrine secretion of bioactive molecules [1]. Instead of the administered cells directly replacing damaged tissue, they act as bioreactors that release a complex mixture of growth factors, cytokines, and chemokines into the local environment [2]. These factors then interact with various receptors on host cells—such as endothelial cells, immune cells, and resident progenitors—to stimulate angiogenesis, modulate the immune response, and promote endogenous repair mechanisms [3]. This indirect approach is central to treating conditions like graft-versus-host disease, myocardial infarction, and chronic inflammation [4]. However, because this mechanism involves a heterogeneous secretome acting on a wide array of host pathways, it lacks a single, well-defined molecular target, presenting challenges for traditional pharmacological characterization and regulatory standardization [5]. This bystander effect is a hallmark of many regenerative medicine products, where the primary goal is to modulate the local microenvironment rather than direct cell replacement [6]. The efficacy of such therapies is often dependent on the dynamic interaction between the secreted factors and the specific pathological environment of the patient [7]. Consequently, the target is not a single molecule but a network of signaling events triggered by the secretome [8]. Sources: [1] Gnecchi M, et al. (2016) Circ Res; [2] Caplan AI, Correa D. (2011) Cell Stem Cell; [3] Vizoso FJ, et al. (2017) Int J Mol Sci; [4] Liang X, et al. (2014) Stem Cells Int; [5] Maguire G. (2013) World J Stem Cells; [6] Teixeira FG, et al. (2013) BioMol Concepts; [7] Murphy MB, et al. (2013) Exp Mol Med; [8] Drago D, et al. (2013) BMC Neurosci.

Other names

Paracrine signalingSecretome-mediated effectsIndirect trophic supportBystander effectMSC secretome

The mechanism involves the paracrine secretion of a diverse array of bioactive factors (the secretome) by therapeutic cells, which subsequently bind to and activate multiple receptors on host cells to modulate inflammation, promote survival, and induce regeneration [1][2].